Righi, Elda

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences

Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers

Cited by 1,099

Epidemiological trends in nosocomial candidemia in intensive care

Bassetti, M., Righi, E., Costa, A., Fasce, R., Molinari, M. P., Rosso, R., Pallavicini, F. B., & Viscoli, C. (2006) · BMC Infectious Diseases

Antifungal resistance and susceptibilityNosocomial Infections in ICU

Cited by 332

A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.

Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Cecilia, T., De Pascale, G., Diaz-Martin, A., Luzzati, R., Rosin, C., Lagunes, L., et al. (2014) · Intensive Care Medicine

Antifungal resistance and susceptibilitySepsis Diagnosis and Treatment

Cited by 284

Epidemiology, species distribution, antifungal susceptibility, and outcome of Candidemia across five sites in Italy and Spain

Bassetti, M., Merelli, M., Righi, E., Diaz-Martin, A., Rosello, E. M., Luzzati, R., Parra, A., Trecarichi, E. M., Sanguinetti, M., Posteraro, B., et al. (2013) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 228

Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?

Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., & Lass-Flörl, C. (2020) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 40